Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DCGO 
DocGo Inc (DCGO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: DCGO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $3.08
1 Year Target Price $3.08
| 3 | Strong Buy |
| 1 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -41.26% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 149.65M USD | Price to earnings Ratio - | 1Y Target Price 3.08 |
Price to earnings Ratio - | 1Y Target Price 3.08 | ||
Volume (30-day avg) 7 | Beta 0.97 | 52 Weeks Range 1.23 - 5.67 | Updated Date 09/17/2025 |
52 Weeks Range 1.23 - 5.67 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.2 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.2% | Operating Margin (TTM) -21.74% |
Management Effectiveness
Return on Assets (TTM) -4.02% | Return on Equity (TTM) -9.07% |
Valuation
Trailing PE - | Forward PE 60.24 | Enterprise Value 105934651 | Price to Sales(TTM) 0.34 |
Enterprise Value 105934651 | Price to Sales(TTM) 0.34 | ||
Enterprise Value to Revenue 0.24 | Enterprise Value to EBITDA 5.57 | Shares Outstanding 97808096 | Shares Floating 85699490 |
Shares Outstanding 97808096 | Shares Floating 85699490 | ||
Percent Insiders 7.31 | Percent Institutions 52.38 |
Upturn AI SWOT
DocGo Inc
Company Overview
History and Background
DocGo Inc. was founded in 2015. It focuses on mobile health and remote patient monitoring services, evolving from a transportation service to a comprehensive healthcare provider.
Core Business Areas
- Mobile Health Services: Provides on-demand medical care delivered to patients' homes, workplaces, or other locations, including urgent care, chronic disease management, and post-acute care.
- Remote Patient Monitoring: Offers technology-enabled remote monitoring services to track patients' health conditions and provide timely interventions.
- Medical Transportation: Provides ambulance and other medical transportation services.
Leadership and Structure
Anthony Capone is the current CEO. The company has a traditional corporate structure with executive leadership overseeing various departments.
Top Products and Market Share
Key Offerings
- Mobile Health Services: On-demand medical care including urgent care, chronic disease management, and post-acute care. Market share data not readily available. Competitors include DispatchHealth, Heal, and traditional urgent care centers.
- Remote Patient Monitoring: Technology-enabled remote monitoring for chronic conditions. Market share data not readily available. Competitors include Teladoc Health, Omron Healthcare, and BioTelemetry.
Market Dynamics
Industry Overview
The healthcare industry is undergoing a shift towards more accessible and convenient care delivery models, with increasing demand for mobile and remote healthcare services.
Positioning
DocGo is positioned as a tech-enabled mobile health provider offering convenient and cost-effective care solutions. Their competitive advantage lies in their integrated platform and scalable infrastructure.
Total Addressable Market (TAM)
The TAM for mobile healthcare and remote patient monitoring is estimated to be in the billions of dollars and growing. DocGo is positioned to capture a significant portion of this market.
Upturn SWOT Analysis
Strengths
- Scalable Technology Platform
- Strong Growth in Revenue
- Experienced Management Team
- First Mover Advantage in Some Markets
Weaknesses
- Dependence on Key Contracts
- High Operating Expenses
- Limited Brand Recognition
- Profitability Concerns
Opportunities
- Expansion into New Geographies
- Partnerships with Healthcare Providers
- Adoption of Remote Patient Monitoring
- Increased Demand for Home Healthcare
Threats
- Increased Competition
- Changes in Healthcare Regulations
- Economic Downturn
- Cybersecurity Risks
Competitors and Market Share
Key Competitors
- AMN Healthcare Services Inc (AMN)
- Teladoc Health Inc (TDOC)
- DispatchHealth (Private)
Competitive Landscape
DocGo offers mobile health services. Competitors offer broader healthcare solutions or focus on specific segments. DocGo's focus can be an advantage but requires efficient execution.
Major Acquisitions
Ambulnz
- Year: 2021
- Acquisition Price (USD millions): 24.5
- Strategic Rationale: Expanded geographic footprint and service offerings.
Growth Trajectory and Initiatives
Historical Growth: DocGo has experienced rapid revenue growth in recent years, driven by increased demand for its mobile health services.
Future Projections: Analysts project continued revenue growth for DocGo, driven by expansion into new markets and increased adoption of its services. Profitability is expected to improve over time.
Recent Initiatives: Recent initiatives include expanding into new markets, launching new service offerings, and investing in technology infrastructure.
Summary
DocGo Inc. is a rapidly growing mobile health company with significant revenue increases, but profitability remains a key concern. Their scalable platform and strategic acquisitions position them well in a growing market, but they must address cost management and increasing competition. Successfully securing large government contracts is vital for continued expansion, as is navigating changes in healthcare regulations. Their innovative platform gives them a competitive edge.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Company Press Releases
- Analyst Reports
- Market Research Reports
- News Articles
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DocGo Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2021-11-05 | CEO & Director Mr. Lee Bienstock | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 3404 | Website https://www.docgo.com |
Full time employees 3404 | Website https://www.docgo.com | ||
DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom. The company offers transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also provides mobile health services through its platform that are performed at home, offices, and other locations; event services, including on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was incorporated in 2015 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.